The P300 is one of the cognitive wave of the Event-Related Potential (ERP) that is used to investigate the cognitive process. The P300 component are accepted as electro-physiological markers of neuropsychiatric disorders like alcoholism or drug addiction. Recent scientific data suggest that eating disorders, leading to weight gain and obesity, will be similar of those of drug addiction: it is the incentive sensitization theory that implicates the dopaminergic reward system. The aim of this cross-sectional study is to investigate the alteration of P300 auditory ERP in obese women with eating disorders in comparison with obese and lean women without eating disorders.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
108
CRNH Rhône-Alpes /CENS Centre Européen pour la Nutrition et la Santé Centre Hospitalier Lyon Sud - Pavillon médical 165, chemin du Grand Revoyet
Pierre-Bénite, France
P300 amplitude
The auditory event-related potentials measure will be elicited with an auditory oddball paradigm. The activity will be recorded thanks to electroencephalography from frontal, central and parietal electrodes, using an electrode cap.
Time frame: At the beginning of the exploration visit (when patient is fasting) that will take place between 1 and 15 days after inclusion
Auditory ERP ( latency P300, amplitude and latency of N2 wave recorded from frontal, central and parietal electrode)
The technique of auditory ERP will be an auditory discriminated task paradigm
Time frame: fasting (up to 15 days)
assessment of dietary restraints and disinhibition
Participants will complete self-report questionnaires including Three-Factor Eating Questionnaire and Eating Disorders Inventory. The lean subjects should not have TFEQ disinhibition score more than 8. The obese subjects will be separated on two groups depending on TFEQ dishinibition score (strictly greater than 8, the obese with eating disorder, less than or equal 8, obese without eating disorder).
Time frame: fasting (up to 15 days)
glucose, insulin, leptin and ghrelin plasmatic rate
respectively reverse-phase high-performance liquid chromatography (RP-HPLC), ImmunoRadio Metric (IRMA) and ELISA assay
Time frame: fasting (up to 15 days)
dopamine D2 receptor Taq 1 polymorphism
Real time PCR
Time frame: fasting (up to 15 days)
Dietary intake and eating patterns
Women will be interviewed by dietician, using a 24 h food questionnaire with additional questions regarding health and eating habits
Time frame: At day 1 and at day 15
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.